Concepedia

Ricardo Restrepo‐Jaramillo

RR

8

Publications

736

Citations

8

H-Index

2018

Active since

Affiliations

University of South Florida(Current)

Methodist Hospital

Arizona Pain Specialists

United Therapeutics (United States)

University of Alabama at Birmingham

Ricardo Restrepo‐Jaramillo is an author at University of South Florida specializing in pharmacotherapy, pulmonary vascular disease, and pulmonary disease.

Top concepts

Publications per year

2018–2024

8

Publications

8

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan et al. · New England Journal of Medicine · 2021 · 556 citations · Full text

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study

Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan et al. · European Respiratory Journal · 2023 · 52 citations · Full text

The neutrophil chemoattractant peptide proline-glycine-proline is associated with acute respiratory distress syndrome

Nirmal Sharma, Charitharth Vivek Lal, Jindong Li et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2018 · 44 citations · Full text

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension

Leslie Spikes, Abubakr Bajwa, Charles D. Burger et al. · Pulmonary Circulation · 2022 · 31 citations · Full text

, , +14

Successful use of subcutaneous ivermectin for the treatment of<i>Strongyloides stercoralis</i>hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population

Kristen Zeitler, Ripal Jariwala, Ricardo Restrepo‐Jaramillo et al. · BMJ Case Reports · 2018 · 15 citations · Full text

Rows per page

1–5 of 8